Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy
Polyp detection rate in colonoscopy following oral administration of methylene blue MMX
modified release tablets in subjects undergoing colonoscopy as outpatients.
- Patients scheduled for screening or surveillance colonoscopy. Written informed
consent.Practising reliable contraception or sterile.Ability to understand and comply
with the protocol.
- Pregnancy or lactation known or suspected hypersensitivity GI obstruction or
perforation serious cardiovascular, renal or hepatic disease. reduced prothrombin
time,elevated serum creatinine.
Type of Study:
Observational Model: Case-Only, Time Perspective: Prospective
Polyp and adenoma detection rate
Outcome Time Frame:
Italy: Aifa-Agenzia Italiana del Farmaco
- Polyp and Adenoma Detection During Colonoscopy